ALIA NUNN: Open Payments
NPI 1447403530 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 116 payments from 42 companies in 2025. Trend: 2023 $1,216 · 2024 $1,699 · 2025 $2,652
Food & beverage: $2,583Education: $68
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $411 |
| AstraZeneca Pharmaceuticals LP | 8 | $241 |
| Merck Sharp & Dohme LLC | 7 | $176 |
| Regeneron Healthcare Solutions, Inc. | 10 | $138 |
| Janssen Biotech, Inc. | 6 | $124 |
| Celgene Corporation | 5 | $121 |
| Daiichi Sankyo Inc. | 4 | $107 |
| PharmaEssentia USA Corporation | 4 | $104 |
| Exelixis Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $89 |
Products named: KISQALI, KEYTRUDA, PLUVICTO, LIBTAYO, BESREMI, REBLOZYL, CABOMETYX, IMFINZI.
Industry payments across TN — which companies pay providers there.
